Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 651–700 of 1,487 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05148767	UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer	recruiting	Phase 4	606	Zhejiang Cancer HospitalOTHER	1	Dec 8, 2021	clinicaltrials
NCT05131841	Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC	unknown	Phase 4	60	Zhejiang Cancer HospitalOTHER	1	Nov 23, 2021	clinicaltrials
NCT04726878